-
CAN ARTIFICIAL INTELLIGENCE ASSISTED SYSTEMATIC LITERATURE REVIEW SUPPORT RIGOROUS EVIDENCE GENERATION? A CASE STUDY ON PREDICTORS OF COPD EXACERBATIONS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PHYSICAL FUNCTION ON HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE: A UK BIOBANK STUDY
Mar 18, 2026, 21:38 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY IN INHALERS
Mar 18, 2026, 21:38 PM -
PATTERNS AND TRENDS OF ANTIDIABETIC MEDICATION USE DURING PREGNANCY IN CHINA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
ZERO-SHOT LUNG CANCER RISK PREDICTION?FROM?LONGITUDINAL?ELECTRONIC?HEALTH RECORDS?WITH CHAIN-OF-AGENTS?FRAMEWORK
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISONS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM RECENT NICE SUBMISSIONS
Mar 18, 2026, 21:38 PM -
AN AI-DRIVEN RANDOM SURVIVAL FOREST MODEL FOR PREDICTING CANCER-SPECIFIC SURVIVAL IN PEDIATRIC NEUROBLASTOMA: A SEER ANALYSIS
Mar 18, 2026, 21:38 PM -
EXAMINING PATIENT AND TUMOR CHARACTERISTICS ASSOCIATED WITH THE RECEIPT OF NEOADJUVANT CHEMOTHERAPY (NAC) AMONG WOMEN WITH EARLY-STAGE HORMONE RECEPTOR-POSITIVE BREAST CANCER
Mar 18, 2026, 21:38 PM -
REAL WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG PATIENTS WITH ASTHMA RECEIVING BIOLOGIC THERAPY: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF BIOLOGICS IN CROHN’S DISEASE: ALIGNMENT WITH HEALTH PLAN COVERAGE REQUIREMENTS
Mar 18, 2026, 21:38 PM -
FROM JOINT CLINICAL ASSESSMENT TO NATIONAL HTA: SIMILARITIES AND DIVERGENCES ACROSS THE EU-MEMBER STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD RISK OF ACUTE KIDNEY FAILURE AFTER SACUBITRIL/VALSARTAN VS ARB AMONG ADULTS =65 WITH HEART FAILURE
Mar 18, 2026, 21:38 PM -
THE NEED TO CONSIDER THE IMPACT OF DRIVERS OF RELATIVE TREATMENT EFFECTS BEYOND TREATMENT CHOICE IN COST-EFFECTIVENESS ANALYSES (CEA)
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF TARGETED PERINATAL DEPRESSION SCREENING FOR HIGH-RISK WOMEN IN CHINA
Mar 18, 2026, 21:38 PM -
PHARMACY BUDGET IMPACT OF EXPANDING MEDICARE COVERAGE FOR GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY UNDER ALTERNATIVE PRICING SCENARIOS
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF 100% WHEY PEPTIDE-BASED FORMULAS IN US ADULTS RECEIVING HOME ENTERAL NUTRITION
Mar 18, 2026, 21:38 PM -
EXPERT CONSENSUS ON TREATMENT GUIDANCE FOR FDA-APPROVED AND SECOND-GENERATION EXON-SKIPPING THERAPIES IN DUCHENE MUSCULAR DYSTROPHY (DMD): A RAND/UCLA MODIFIED DELPHI PANEL
Mar 18, 2026, 21:38 PM -
COST OF AMPUTATION FOLLOWING LOWER EXTREMITY ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
Mar 18, 2026, 21:38 PM -
A MULTI-MODEL LARGE LANGUAGE FRAMEWORK FOR AUTOMATING SYSTEMATIC LITERATURE REVIEWS
Mar 18, 2026, 21:38 PM -
ANALYSIS OF FDA REVIEW COMMENTS ON PATIENT-REPORTED OUTCOMES IN NEW DRUG APPLICATIONS(2021-2025)
Mar 18, 2026, 21:38 PM
